FDA approves first drug-eluting stent to treat peripheral arterial disease (PAD)

The U.S. Food and Drug Administration today approved the Zilver PTX Drug-Eluting Peripheral Stent (Zilver PTX Stent), the first drug-eluting stent indicated to re-open a particular artery in the thigh (femoropopliteal artery) when narrowed or blocked as a result of peripheral artery disease (PAD).
Learn more here.